Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Vitamin D3 may protect rat hair follicles from radiation damage.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Sodium selenate was found to be safe and possibly slows Alzheimer's progression, but more research is needed.

Biomaterials combined with stem cells show promise for improving tissue repair and medical treatments.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Fat from the body can help improve hair growth and scars when used in skin treatments.

Finasteride may help treat chronic CSC, improving vision.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.